See analyst estimates and all valuation multiples for Medical Imaging & Diagnostics
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$293B | 4.3x | 11.2x | |
$48.2B | 2.4x | 13.0x | |
$40.7B | 6.2x | 21.0x | |
$26.6B | 2.0x | 12.0x | |
$25.7B | 2.6x | 13.1x | |
$21.0B | 12.5x | -118.7x | |
$16.0B | 5.8x | 18.7x | |
$14.4B | 3.5x | 15.0x | |
$10.9B | 3.9x | 32.1x | |
$8.8B | 4.4x | 12.1x | |
$6.4B | 5.1x | 15.4x | |
$6.4B | 11.8x | 82.1x | |
$5.8B | 7.7x | -22.9x | |
$5.4B | 2.9x | 19.0x | |
$5.2B | 3.4x | 7.5x | |
$2.8B | 6.2x | 30.0x | |
$2.4B | 8.5x | 30.5x | |
$2.3B | 0.9x | 5.0x | |
$2.0B | 3.3x | 22.6x | |
$1.6B | 2.4x | 39.2x | |
$1.6B | 1.2x | 4.7x | |
$1.6B | 5.3x | 36.7x | |
$1.5B | 3.2x | 10.7x | |
$1.4B | n/a | n/a | |
$1.3B | 1.6x | 36.1x | |
$1.3B | 30.7x | -50.4x | |
$1.2B | 1.8x | -10.2x | |
$1.2B | n/a | n/a | |
$881M | 2.4x | 12.0x | |
$771M | 6.8x | 15.0x | |
$685M | 5.3x | -0.4x | |
$651M | 1.4x | 5.2x | |
$626M | 111.4x | -18.9x | |
$593M | 2.1x | 7.8x | |
$533M | 2.3x | 11.2x | |
$467M | 1.5x | 7.9x | |
$393M | n/a | n/a | |
$365M | 3.0x | 4.9x | |
$302M | 5.6x | 17.3x | |
$298M | n/a | n/a | |
$273M | 0.2x | 4.3x | |
$256M | n/a | n/a | |
$243M | 12.0x | -46.5x | |
$159M | 2.1x | -7.5x | |
$141M | 25.7x | -3.4x | |
$130M | 2.0x | 9.1x | |
$126M | n/a | n/a | |
$113M | 13.3x | -60.8x | |
$97.9M | 25.1x | n/a | |
$82.1M | 5.1x | -27.2x | |
$78.5M | n/a | n/a | |
$70.8M | n/a | n/a | |
$63.8M | 1.1x | -6.2x | |
$62.6M | 69.7x | n/a | |
$59.0M | 4.0x | 25.6x | |
$57.0M | n/a | n/a | |
$57.0M | n/a | -11.8x | |
$52.8M | 2.8x | -10.4x | |
$47.9M | n/a | n/a | |
$41.7M | n/a | n/a | |
$39.4M | 9.5x | -3.7x | |
$36.7M | n/a | n/a | |
$33.4M | 2.3x | -0.8x | |
$27.1M | n/a | -2.6x | |
$26.5M | 4.1x | -121.5x | |
$23.7M | n/a | n/a | |
$23.7M | 198.1x | -14.6x | |
$19.0M | n/a | n/a | |
-$14.9M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Medical Imaging & Diagnostics